Glaukos Corp
(STU:6GJ)
€
119
0 (0%)
Market Cap: 6.82 Bil
Enterprise Value: 6.73 Bil
PE Ratio: 0
PB Ratio: 11.05
GF Score: 64/100 Glaukos Corp at Stifel Healthcare Conference Transcript
Nov 14, 2023 / 03:55PM GMT
Release Date Price:
€59.5
(+2.59%)
Thomas M. Stephan
Stifel, Nicolaus & Company, Incorporated, Research Division - Associate
I think we'll get started. Tom Stephan with Stifel. Excited to have Glaukos with us here today. With us, we have Joe Gilliam, President and COO; Alex Thurman, CFO; and Chris Lewis, Vice President of IR and Corporate Affairs.
Questions & Answers
Thomas M. Stephan
Stifel, Nicolaus & Company, Incorporated, Research Division - Associate
I'll start off with our least favorite acronym, LCDs. All LCDs finalized set to go into effect at year-end. I'll start with pretty direct question. Joe, Alex, how are you guys thinking about MIGS unit volume in the U.S. market in 2024?
Notably, when taking into account potential preclusion of combination mix procedures, we've done some math. We kind of think U.S. MIGS market volume might be down 5% to 10%, but just your thoughts on what units look like next year?
Joseph E. Gilliam
Glaukos Corporation - President & COO
Well, first, thanks for having us, Tom. We
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot